Authors:
AVILES A
NAMBO MJ
CUADRA I
DELGADO S
TALAVERA A
Citation: A. Aviles et al., TREATMENT AND PROGNOSIS IN PATIENTS WITH PRIMARY GASTRIC MALT LYMPHOMA, Cancer research, therapy & control, 5(4), 1998, pp. 291-294
Authors:
AVILES A
GARCIA EL
TALAVERA A
NAMBO MJ
HUERTAGUZMAN J
DIAZMAQUEO D
Citation: A. Aviles et al., INTERFERON-ALPHA-2B AND LOW-DOSES OF METHOTREXATE IN PATIENTS WITH ADVANCED-STAGE MYCOSIS-FUNGOIDES, Cancer research, therapy & control, 5(4), 1998, pp. 337-340
Authors:
AVILES A
DIAZMAQUEO JC
TALAVERA A
GARCIA EL
GUZMAN R
NAMBO MJ
Citation: A. Aviles et al., BONE-MARROW PROTECTION WITH AMIFOSTINE IN THE TREATMENT OF HIGH-RISK MALIGNANT-LYMPHOMA, European journal of cancer, 33(8), 1997, pp. 1323-1325
Authors:
AVILES A
NAMBO MJ
TALAVERA A
GARCIA EL
HUERTAGUZMAN J
MAQUEO JCD
Citation: A. Aviles et al., EPIRUBICIN (CEOP-BLEO) VERSUS IDAURUBICIN (CIOP-BLEO) IN THE TREATMENT OF ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - DOSE-ESCALATION STUDIES, Anti-cancer drugs, 8(10), 1997, pp. 937-942
Authors:
AVILES A
TALAVERA A
NERI N
NAMBO MJ
DIAZMAQUEO JC
Citation: A. Aviles et al., INTENSIVE CHEMOTHERAPY AND GM-CSF AS HEMATOLOGICAL SUPPORT IN THE TREATMENT OF HIGH-RISK MALIGNANT-LYMPHOMA, Blood, 90(10), 1997, pp. 841-841
Authors:
ALVILES A
NAMBO MJ
DIAZMAQUEO JC
TALAVERA A
VASQUEZ E
GRACIA EL
Citation: A. Alviles et al., HEMATOPOIETIC GROWTH-FACTORS - RESULTS OF A CONTROLLED CLINICAL-TRIALCOMPARING INDIVIDUAL GROWTH-FACTOR THERAPY, Journal of experimental & clinical cancer research, 15(4), 1996, pp. 381-385
Authors:
AVILES A
GUZMAN R
DELGADO S
NAMBO MJ
GARCIA EL
DIAZMAQUEO JC
Citation: A. Aviles et al., INTENSIVE BRIEF CHEMOTHERAPY WITH HEMATOPOIETIC GROWTH-FACTORS AS HEMATOLOGICAL SUPPORT AND ADJUVANT RADIOTHERAPY IMPROVE THE PROGNOSIS IN AGGRESSIVE MALIGNANT-LYMPHOMA, American journal of hematology, 52(4), 1996, pp. 275-280
Authors:
AVILES A
NAMBO MJ
ROSAS A
TALAVERA A
HUERTA J
Citation: A. Aviles et al., COMBINED SURGERY AND CHEMOTHERAPY FOR THE TREATMENT OF PRIMARY INTESTINAL MALIGNANT-LYMPHOMA, GI cancer, 1(1), 1995, pp. 45-48
Citation: A. Aviles et al., USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF INFECTION AND SEVERE GRANULOCYTOPENIA, Cancer research, therapy & control, 4(3), 1995, pp. 157-161
Authors:
AVILES A
NAMBO MJ
TALAVERA A
ROSAS A
GARCIA EL
DIAZMAQUEO JC
Citation: A. Aviles et al., CM-CSF INSTEAD OF HEMATOLOGICAL SUPPORT DURING HIGH-DOSE CHEMOTHERAPYFOR REFRACTORY MALIGNANT-LYMPHOMA, Leukemia & lymphoma, 17(3-4), 1995, pp. 327-330
Authors:
AVILES A
SOTO B
GUZMAN R
GARCIA EL
NAMBO MJ
DIAZMAQUEO JC
Citation: A. Aviles et al., RESULTS OF A RANDOMIZED STUDY OF EARLY-STAGE HODGKINS-DISEASE USING ABVD, EBVD, OR MBVD, Medical and pediatric oncology, 24(3), 1995, pp. 171-175
Authors:
AVILES A
DELGADO S
DIAZMAQUEO JC
NAMBO MJ
GARCIA EL
Citation: A. Aviles et al., TREATMENT OF POOR-PROGNOSIS MALIGNANT-LYMPHOMA USING INTENSIVE BRIEF CHEMOTHERAPY AND ADJUVANT RADIOTHERAPY, Blood, 86(10), 1995, pp. 3218-3218
Authors:
AVILES A
DIAZMAQUEO JC
TALAVERA A
NAMBO MJ
GARCIA EL
Citation: A. Aviles et al., EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH INTENSIVE CHEMOTHERAPY, Leukemia & lymphoma, 15(1-2), 1994, pp. 153-157
Authors:
AVILES A
DELGADO S
FERNANDEZ A
NAMBO MJ
ROSAS A
Citation: A. Aviles et al., COMBINED THERAPY FOR ANGIOIMMUNOPROLIFERATIVE LESIONS, European journal of cancer. Part B, Oral oncology, 30B(5), 1994, pp. 302-304
Authors:
AVILES A
DELGADO S
NAMBO MJ
ALATRISTE S
DIAZMAQUEO JC
Citation: A. Aviles et al., ADJUVANT RADIOTHERAPY TO SITES OF PREVIOUS BULKY DISEASE IN PATIENTS STAGE-IV DIFFUSE LARGE-CELL LYMPHOMA, International journal of radiation oncology, biology, physics, 30(4), 1994, pp. 799-803
Citation: A. Aviles et al., INTERFERON-ALFA 2B IN THE MAINTENANCE THERAPY OF LOW-GRADE NON-HODGKINS-LYMPHOMA, Blood, 84(10), 1994, pp. 10000166-10000166
Authors:
AVILES A
AREVILA N
MAQUEO JCD
GOMEZ T
GARCIA R
NAMBO MJ
Citation: A. Aviles et al., LATE CARDIAC TOXICITY OF DOXORUBICIN, EPIRUBICIN, AND MITOXANTRONE THERAPY FOR HODGKINS-DISEASE IN ADULTS, Leukemia & lymphoma, 11(3-4), 1993, pp. 275-279
Authors:
AVILES A
ALATRISTE S
DIAZMAQUEO JC
NAMBO MJ
TALAVERA A
GARCIA EL
Citation: A. Aviles et al., INTENSIVE ALTERNATING CHEMOTHERAPY (IAC) PLUS INTERFERON-ALPHA-2B (IFN) INCREASE SURVIVAL IN PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA (MM), Blood, 82(10), 1993, pp. 10000558-10000558